Table of Contents Table of Contents
Previous Page  303 / 398 Next Page
Information
Show Menu
Previous Page 303 / 398 Next Page
Page Background

298

4–5%. The early detection of high malignant transformation in

OPMD patients is very import.

Methods:

Paired oral cancer/OPMD surgical specimens were

obtained. Gene analysis of exomes was done by next generation

sequencing, (NGS).

Results:

The gene mutation rate was increased in the progression

of OPMD to oral cancer. The chromosome 4 and 17 had more

mutations in oral cancer specimens. Positive correlation of gene

mutation and malignant transformation of OPMD was found.

Conclusion:

Gene mutation was increased in the transformation

of OPMD to oral cancer. Our study might be useful to develop

chemical prevention agent to prevent malignant transformation in

oral pre-cancer lesions.

http://dx.doi.org/10.1016/j.ijom.2017.02.1001

Clinicopathological characteristics and outcomes of

squamous cell carcinoma of the tongue in different age

groups

Y.Y. Zhang

∗

, D.C. Wang, J.Z. Su, L.F. Jia, X. Peng, G.Y. Yu

Peking University School and Hospital of Stomatology, China

Background:

The clinicopathological features and outcomes of

squamous cell carcinoma (SCC) of the tongue in patients of dif-

ferent age groups remain debatable.

Objectives:

To evaluate biological behaviours and outcomes of

tongue SCC in different age groups.

Methods:

Medical records of 457 patients with tongue SCC were

reviewed, grouped by age, and followed up. The clinicopatholog-

ical features of the tumours and patients’ outcomes in different

age groups were compared.

Findings and conclusion:

Gender, TNM stage, disease-free sur-

vival (DFS), and disease-specific survival (DSS) showed no

inter-group differences. Patients aged 46–59 years had the most

severe smoking and drinking habits (42.9% and 35.3%, respec-

tively). Tongue SCC in patients’

≤

30 years had the most advanced

TNM stage and the greatest proportion of poorly differentiated

tumours. The death rate caused by recurrence or metastasis in

the youngest group was much higher than the other two groups

(91.7% versus 75.4% and 77.4%, respectively). Young patients

had higher incidence of distant metastasis and recurrence death

rate than middle-aged and oldest patients.

http://dx.doi.org/10.1016/j.ijom.2017.02.1002

Brown tumour of the mandible: report of two cases and

review of the literature

H.X. Zou

∗

, J. Jia, Y.F. Zhao

Wuhan University, Wuhan, China

Objectives:

Brown tumours are non-neoplastic lesions resulting

from abnormal bone metabolism in hyperparathyroidism. The

mandible involvement is exceptional, we describe such two cases

and highlight the importance of taking a comprehensive history

and focusing the investigations so that appropriate treatment can

be given.

Methods:

A retrospective analysis of two cases of mandibular

brown tumour patients in our hospital, one case occurred in the

anterior portion of the mandible, another case occurred in the

maxilla and mandible involved femur, ribs and skull. The clinical

features, laboratory investigations, pathological characteristics,

imaging findings and treatment were retrospectively analysed.

Findings:

Both patients showed weight loss, fatigue, anorexia,

nausea, pain and decreased bone density, high levels of serum cal-

cium, alkaline phosphatase, urinary calcium, parathyroid hormone

and lower levels of serum phosphorus and urinary calculi history,

X-ray showed decreased bone density, extensive fibrosis, cys-

tic degeneration. Histopathological examination showed a lesion

with newly formed bone tissue, diffuse giant cells and deposits of

haemosiderin in a background of fibrovascular proliferation.

Conclusion:

The diagnosis of mandibular brown tumour was

suggested by the clinical history and confirmed by labo-

ratory investigations including calcium, phosphorus, alkaline

phosphatase, parathormone assays, computed tomography and

histopathological determinations. For mandibular cystic lesions

associated with urinary tract stones, hypercalcaemia, osteoporo-

sis, brown tumours should be highly suspected. A majority of

these lesions may disappear with the removal of the parathyroid

pathology.

http://dx.doi.org/10.1016/j.ijom.2017.02.1003

Oral and Maxillofacial Pathology

Enucleation with adjuvant therapy as treatment modality for

ameloblastoma — a retrospective analysis of 10 years

A. Akare

∗

, A. Datarkar, P. Pandilwar

Government Dental College and Hospital, Nagpur, India

Background:

Ameloblastoma is a rare odontogenic neoplasm of

the mandible and maxilla, with multiple histologic variants, and

high recurrence rates if improperly treated. Historically, the extent

of resection has been controversial, comprising of two surgical

options: ‘conservative’ versus ‘radical’.

Objective:

The aim of this presentation is to retrospectively eval-

uate the patients with ameloblastoma treated in our department

with enucleation and adjuvant therapy followed for 10 years.

Methods:

A retrospective study was done in the Department of

Oral and Maxillofacial Surgery, Government Dental College and

Hospital, Nagpur. The demographic data was collected retrospec-

tively from89 patients, and clinical and radiographic features were

carefully documented. Type of ameloblastoma, size and site of

lesion, sufficient amount of remaining healthy bone, and the type

of treatment, received conservative as enucleation, along with or

without adjuvant therapy or radical resection were studied.

Result:

Total of 89 patients presented to the department with

pathology, of whom 39 patients (mean age, 30 years) were

diagnosed as Ameloblastoma and included in the study. Radio-

graphically shows unilocular and multilocular radiolucency,

histologically reported unicystic/mural ameloblastoma or plex-

iform ameloblastoma were treated by enucleation along with

adjuvant therapy and under follow-up for past 10 years.

Conclusion:

Therapeutically, simple enucleation has no role in

the management of ameloblastoma but the study concluded that

enucleation along with the adjuvant therapy has played impor-

tant role in treating ameloblastoma perhaps the unicystic subtype.

Advantages of enucleation include the fact that it requires no

reconstruction.

http://dx.doi.org/10.1016/j.ijom.2017.02.1004